Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB - Nasdaq - US7194051022 - Common Stock - Currency: USD

19.96  +0.17 (+0.86%)

After market: 19.95 -0.01 (-0.05%)

Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! This makes PLAB very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
In the past year PLAB had a positive cash flow from operations.
PLAB had positive earnings in each of the past 5 years.
PLAB had a positive operating cash flow in each of the past 5 years.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

The Return On Assets of PLAB (7.04%) is better than 73.64% of its industry peers.
PLAB has a better Return On Equity (10.90%) than 71.82% of its industry peers.
PLAB's Return On Invested Capital of 10.42% is fine compared to the rest of the industry. PLAB outperforms 80.00% of its industry peers.
PLAB had an Average Return On Invested Capital over the past 3 years of 12.91%. This is above the industry average of 10.79%.
Industry RankSector Rank
ROA 7.04%
ROE 10.9%
ROIC 10.42%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

With a decent Profit Margin value of 14.00%, PLAB is doing good in the industry, outperforming 71.82% of the companies in the same industry.
In the last couple of years the Profit Margin of PLAB has grown nicely.
With an excellent Operating Margin value of 25.20%, PLAB belongs to the best of the industry, outperforming 84.55% of the companies in the same industry.
PLAB's Operating Margin has improved in the last couple of years.
The Gross Margin of PLAB (36.29%) is worse than 64.55% of its industry peers.
In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 25.2%
PM (TTM) 14%
GM 36.29%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PLAB is still creating some value.
Compared to 1 year ago, PLAB has more shares outstanding
The number of shares outstanding for PLAB has been reduced compared to 5 years ago.
PLAB has a better debt/assets ratio than last year.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

PLAB has an Altman-Z score of 3.18. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.18, PLAB is in line with its industry, outperforming 50.91% of the companies in the same industry.
The Debt to FCF ratio of PLAB is 0.00, which is an excellent value as it means it would take PLAB, only 0.00 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.00, PLAB belongs to the best of the industry, outperforming 84.55% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
PLAB has a Debt to Equity ratio of 0.00. This is in the better half of the industry: PLAB outperforms 71.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.18
ROIC/WACC0.96
WACC10.82%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.13 indicates that PLAB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.13, PLAB is in the better half of the industry, outperforming 75.45% of the companies in the same industry.
A Quick Ratio of 4.76 indicates that PLAB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.76, PLAB belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.13
Quick Ratio 4.76
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

PLAB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.98%.
The Earnings Per Share has been growing by 33.90% on average over the past years. This is a very strong growth
PLAB shows a decrease in Revenue. In the last year, the revenue decreased by -3.19%.
The Revenue has been growing by 9.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%

3.2 Future

PLAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.07% yearly.
Based on estimates for the next years, PLAB will show a small growth in Revenue. The Revenue will grow by 0.93% on average per year.
EPS Next Y-11.62%
EPS Next 2Y1.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.04%
Revenue Next 2Y0.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.88, which indicates a very decent valuation of PLAB.
97.27% of the companies in the same industry are more expensive than PLAB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.24, PLAB is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.87, the valuation of PLAB can be described as reasonable.
Based on the Price/Forward Earnings ratio, PLAB is valued cheaply inside the industry as 97.27% of the companies are valued more expensively.
PLAB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.42.
Industry RankSector Rank
PE 9.88
Fwd PE 9.87
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

PLAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PLAB is cheaper than 99.09% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PLAB is valued cheaper than 92.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.35
EV/EBITDA 2.07
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2Y1.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (8/4/2025, 8:00:00 PM)

After market: 19.95 -0.01 (-0.05%)

19.96

+0.17 (+0.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-28 2025-05-28/bmo
Earnings (Next)08-28 2025-08-28/bmo
Inst Owners90.34%
Inst Owner Change-0.27%
Ins Owners3.77%
Ins Owner Change4.25%
Market Cap1.20B
Analysts84.44
Price Target31.84 (59.52%)
Short Float %5.06%
Short Ratio4.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.34%
Min EPS beat(2)-19.14%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-2.54%
Min EPS beat(4)-19.14%
Max EPS beat(4)11.24%
EPS beat(8)3
Avg EPS beat(8)-3.56%
EPS beat(12)5
Avg EPS beat(12)-0.54%
EPS beat(16)9
Avg EPS beat(16)5.15%
Revenue beat(2)0
Avg Revenue beat(2)-1.71%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-2.84%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)1
Avg Revenue beat(8)-3.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.45%
Revenue beat(16)7
Avg Revenue beat(16)-0.66%
PT rev (1m)0%
PT rev (3m)-12.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.13%
Valuation
Industry RankSector Rank
PE 9.88
Fwd PE 9.87
P/S 1.4
P/FCF 13.35
P/OCF 4.74
P/B 1.09
P/tB 1.09
EV/EBITDA 2.07
EPS(TTM)2.02
EY10.12%
EPS(NY)2.02
Fwd EY10.13%
FCF(TTM)1.49
FCFY7.49%
OCF(TTM)4.21
OCFY21.1%
SpS14.24
BVpS18.3
TBVpS18.3
PEG (NY)N/A
PEG (5Y)0.29
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 10.9%
ROCE 14.05%
ROIC 10.42%
ROICexc 16.37%
ROICexgc 16.37%
OM 25.2%
PM (TTM) 14%
GM 36.29%
FCFM 10.49%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 200.08%
Cap/Sales 19.08%
Interest Coverage 250
Cash Conversion 85.14%
Profit Quality 74.94%
Current Ratio 5.13
Quick Ratio 4.76
Altman-Z 3.18
F-Score5
WACC10.82%
ROIC/WACC0.96
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
EPS Next Y-11.62%
EPS Next 2Y1.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%
Revenue Next Year-3.04%
Revenue Next 2Y0.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.39%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year34.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.55%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-10.03%
OCF growth 3Y20.13%
OCF growth 5Y30.76%